We are live on ! Find out more
CPIX icon

Cumberland Pharmaceuticals
CPIX

28 hedge funds and large institutions have $8.36M invested in Cumberland Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 11 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.09% less ownership

Funds ownership: 21.62% → 19.53% (-2.1%)

10% less funds holding

Funds holding: 31 → 28 (-3)

14% less capital invested

Capital invested by funds: $9.77M → $8.36M (-$1.41M)

64% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 11

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
28
Holders Change
-3
Holders Change %
-9.68%
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
4
Reduced
11
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$95.8K
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$51.8K
3
BAM
Berkshire Asset Management
Pennsylvania
+$15.7K
4
Wells Fargo
Wells Fargo
California
+$5.88K

Top Sellers

Rank Fund Capital Flow
1
AI
Ariel Investments
Illinois
-$589K
2
Renaissance Technologies
Renaissance Technologies
New York
-$152K
3
California Public Employees Retirement System
California Public Employees Retirement System
California
-$115K
4
Citadel Advisors
Citadel Advisors
Florida
-$52K
5
MHS
M Holdings Securities
Oregon
-$33K
Name Holding Trade Value Shares
Change 		Change in
Stake
Dimensional Fund Advisors
1
Dimensional Fund Advisors
Texas
$2.15M +$51.8K +17,619 +2%
Renaissance Technologies
2
Renaissance Technologies
New York
$2M -$152K -51,590 -7%
BlackRock
3
BlackRock
New York
$1.13M +$95.8K +32,579 +9%
Vanguard Group
4
Vanguard Group
Pennsylvania
$1.11M – – –
BAM
5
Berkshire Asset Management
Pennsylvania
$486K +$15.7K +5,335 +3%
Acadian Asset Management
6
Acadian Asset Management
Massachusetts
$480K -$19.4K -6,609 -4%
BCM
7
Bridgeway Capital Management
Texas
$436K -$8.24K -2,800 -2%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$146K – – –
SFP
9
Sterling Financial Planning
New Jersey
$63K – – –
Northern Trust
10
Northern Trust
Illinois
$58K – – –
Bank of New York Mellon
11
Bank of New York Mellon
New York
$56K – – –
UCFA
12
United Capital Financial Advisors
Texas
$46K – – –
PPA
13
Parametric Portfolio Associates
Washington
$38K -$6.83K -2,322 -15%
AI
14
Ariel Investments
Illinois
$34K -$589K -200,337 -94%
Arrowstreet Capital
15
Arrowstreet Capital
Massachusetts
$30K – – –
California Public Employees Retirement System
16
California Public Employees Retirement System
California
$29K -$115K -39,015 -79%
Cambridge Investment Research Advisors
17
Cambridge Investment Research Advisors
Iowa
$28K – – –
Russell Investments Group
18
Russell Investments Group
United Kingdom
$15K – – –
Morgan Stanley
19
Morgan Stanley
New York
$9K -$23.5K -8,000 -72%
OC
20
Oakworth Capital
Alabama
$9K – – –
Wells Fargo
21
Wells Fargo
California
$6K +$5.88K +2,000 +3,636%
TRCT
22
Tower Research Capital (TRC)
New York
$2K -$115 -39 -5%
Osaic Holdings
23
Osaic Holdings
Arizona
$2K – – –
UBS Group
24
UBS Group
Switzerland
$1K -$7.4K -2,514 -84%
PAM
25
Panagora Asset Management
Massachusetts
$1K -$68 -23 -5%
1
2

CPIX Hedge Fund Activity: Q2 2021 in Review

28 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q2 2021, worth a combined $8.36M — down 14% from $9.77M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of CPIX and 0 opened new positions — a net loss of 3 holders — while 11 trimmed existing stakes and 4 added.

The largest buyer was BlackRock, adding an estimated $95.8K. The largest seller was Ariel Investments, cutting an estimated $589K.

  • 28 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q2 2021, down from 31 in Q1 2021.
  • Funds reported $8.36M of Cumberland Pharmaceuticals stock for Q2 2021, down 14% quarter-over-quarter.
  • 0 funds opened new Cumberland Pharmaceuticals positions in Q2 2021 and 3 closed out, a net change of -3 holders.
  • The largest Cumberland Pharmaceuticals buyer in Q2 2021 was BlackRock, an estimated $95.8K added.
  • The largest Cumberland Pharmaceuticals seller in Q2 2021 was Ariel Investments, an estimated $589K sold.

Based on aggregated 13F filings for Q2 2021.